Table 3.
Differences (Δ) in transformed (0-100 scale) median SF-36 domain scores including PCS and MCS scores in subjects with unoperated TAD compared to an age- and sex-matched reference group from the normal population (n = 178 in both groups)
SF-36 domain | TAD median transformed score (IQR) n (%) | Reference group median transformed score (IQR) n (%) | Δ Median (TAD-Reference) [95% CL] |
---|---|---|---|
PF | 75 (35) | 85 (34) | −10 [−15, −4.5] |
RP | 75 (75) | 100 (50) | −25 [−34, −16] |
BP | 74 (49) | 74 (59) | 0 [−5.8, 5.8] |
GH | 62 (32) | 67 (33) | −5 [−9.7, −0.27] |
VT | 70 (40) | 70 (35) | 0 [−5.2, 5.2] |
SF | 100 (25) | 100 (25) | 0 [−5.2, 5.2] |
RE | 100 (67) | 100 (67) | 0 [−8.2, 8.2] |
MH | 80 (28) | 84 (28) | −4 [−8.3, 0.3] |
PCS | 43 (18) | 50 (17) | −6.4 [−8.8, −4.0] |
MCS | 54 (14) | 54 (12) | −0.37 [−2.8, 2.1] |
PCS indicates physical component summary; MCS, mental component summary; TAD, thoracic aortic disease; IQR, interquartile range; CL, confidence limit; PF, physical functioning; RP, role physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health.